Search results for: 'Preferred Destination for Early Phase Clinical Trials'

Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of the global pharmaceutical industry. The global IVD market size was $47.30 billion in 2013; it is expected to reach $62.63 billion in 2017, at a compound annual growth rate of 7.3%. Because of stagnating mature markets, comp...

This research service evaluates the U.S. medical ultrasound imaging systems market over the 2007 to 2015 time period. It provides background information and an overview of the market, specifies important market metrics, identifies key market drivers and restraints, and evaluates ongoing technology trends, market competitors, product offerings and k...

This Frost & Sullivan research service covers the state of the China Healthcare Information Technology Market, examining drivers and restraints for growth, pricing, technology, legislation, demand and geographical trends. In addition, an in-depth analysis of the competitive situation is performed. The market is further divided into two sub segment...

The clinical capabilities of interventional radiology (IR) have developed faster than any other area of medicine. Along with parallel technology evolution in computer technology, medical physics and developments in endovascular catheter technology, interventional radiologists are slowing replacing major open surgeries with minimally invasive and le...

Both predictive and prognostic biomarkers constitutes an central element in each and every targeted oncology drug discovery and development program. Breakthrough technologies allowing leveraging biomarkers for oncology are paving the way of personalized medicine and precision oncology. Indeed, oncology biomarkers provide the clinical community with...

The impressive advances in life sciences research and development (R&D) befallen in the past two-three years are playing a leading role in the transformation of the healthcare industry. A myriad of new developments in the fields of gene and cell therapies, empowered with nanotechnology advances, omics technologies and novel smart molecules approach...

This research service encompasses a comprehensive analysis of minimally-invasive and non-invasive biopsy platforms that enable enhanced tumor profiling, treatment monitoring and precision oncology applications. This service primarily focuses on the use of circulating tumor DNA (ctDNA) circulating tumor cells (CTCs) and extracellular vesicles (EVs),...

In this report, Frost & Sullivan profiles upcoming global trends in health, wellness, and nutrition that help accelerate advancements in this space. The six trends covered are personalized disease management, clinical decision support systems, virtual wellness programs, healthy aging, functional beverages, and wellness metaverse. Under each trend, ...

Globally, the US continues to be the leading market to test and launch vehicle subscription offers. Frost & Sullivan estimates about 32 vehicle subscription programs in the US at various stages of life cycle in 2018, and it is expected to witness more than 50 programs by 2025. Frost & Sullivan carried out more than 2000 interviews among potential c...